Therapeutic use of nalbuphine without aquaretic effects 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
WO2017120468 A1 2017-07-13 [WO2017120468] / 2017-07-13
申请号/申请日
2017WO-US12530 / 2017-01-06
发明人
SCIASCIA THOMAS;
申请人
TREVI THERAPEUTICS;
主分类号
IPC分类号
A61K-031/485A61P-017/04C07D-489/04
摘要
(WO2017120468) The present invention relates to methods for treating pruritus with anti-pruritic compositions, wherein the method provides a therapeutic effect without producing a substantial aquaretic effect.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2016US-62275394 2016-01-06
主权利要求

        
法律状态
(WO2017120468) LEGAL DETAILS FOR WO2017120468  Actual or expected expiration date=2019-07-06    Legal state=ALIVE    Status=PENDING     Event publication date=2017-01-06  Event code=WO/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=WO WOUS2017012530  Application date=2017-01-06  Standardized application number=2017WO-US12530     Event publication date=2017-07-13  Event code=WO/A1  Event type=Examination events  Published application with search report  Publication country=WO  Publication number=WO2017120468  Publication stage Code=A1  Publication date=2017-07-13  Standardized publication number=WO2017120468
专利类型码
A1
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部